title: Effect of vitamin D on bioavailability and lipid lowering efficacy of simvastatin.
abstract: The 3-hydroxy 3-methylglutaryl coenzyme A reductase (HMG-CoA reductase) inhibitors known as "statins" are widely prescribed for the management of dyslipidemia. In spite of their muscle toxicity, use of statins has alarmingly increased worldwide. A recent report suggests that vitamin D (VD) levels are closely associated with lipid lowering activity and muscular toxicity of statins. However, data are limited and inconclusive. The present study was undertaken to investigate the effect of VD supplementation on the bioavailability and lipid lowering effect of simvastatin (ST). Adult Sprague-Dawley male rats (250 ± 10 g) were divided into four groups including control, ST (100 mg/kg/day), VD (100 μg/kg/day) and ST + VD group, respectively. After the dosing period of 8 days the animals were sacrificed and the blood was collected for the analysis of ST, its active metabolite simvastatin acid (STA), total cholesterol, triglyceride and liver enzymes including aspartate transaminase and alanine transaminase. The result of this study showed a significant decrease in the level of cholesterol and triglyceride in ST alone treated group, whereas VD alone failed to alter the blood lipid levels. Concomitant treatment with VD produced significant decrease in the bioavailability of ST and STA. However, there was no significant difference in the level of cholesterol in ST alone and in ST + VD treated group. Our results on the liver enzyme suggest that ST alone or in combination with VD does not produce any hepatotoxicity. Further studies using VD along with various statins for a longer duration are suggested.
authors.affiliation: Research Center, Prince Sultan Medical Military City, P.O. Box k-486, Riyadh, 11159, Saudi Arabia, abdulrahman.alasmari@gmail.com.
authors.forename: Abdulrahman K
authors.initials: AK
authors.lastname: Al-Asmari
authors.forename: Zabih
authors.initials: Z
authors.lastname: Ullah
authors.forename: Fahad
authors.initials: F
authors.lastname: Al-Sabaan
authors.forename: Mohammad
authors.initials: M
authors.lastname: Tariq
authors.forename: Ahmed
authors.initials: A
authors.lastname: Al-Eid
authors.forename: Saud F
authors.initials: SF
authors.lastname: Al-Omani
mesh_terms: D000284:Administration, Oral; D000818:Animals; D001682:Biological Availability; D015415:Biomarkers / Q000097:blood; D001711:Biotransformation; D002762:Cholecalciferol / Q000008:administration & dosage*; D002784:Cholesterol / Q000097:blood; D015536:Down-Regulation; D004347:Drug Interactions; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000008:administration & dosage* / Q000493:pharmacokinetics*; D008099:Liver / Q000187:drug effects* / Q000378:metabolism; D008297:Male; D017207:Rats, Sprague-Dawley; D018570:Risk Assessment; D019821:Simvastatin / Q000008:administration & dosage* / Q000031:analogs & derivatives / Q000097:blood / Q000493:pharmacokinetics*; D014280:Triglycerides / Q000097:blood
chemical_list: D015415:Biomarkers; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D014280:Triglycerides; D002762:Cholecalciferol; D002784:Cholesterol; C063287:simvastatin acid; D019821:Simvastatin
references.citation: Circulation. 2001 Feb 20;103(7):993-9
references.pmid: 11181475
references.citation: Am J Cardiol. 2007 Feb 1;99(3):410-4
references.pmid: 17261409
references.citation: Circulation. 1998 Sep 1;98(9):839-44
references.pmid: 9738637
references.citation: Lancet. 2012 Aug 11;380(9841):581-90
references.pmid: 22607822
references.citation: N Engl J Med. 2007 Jul 19;357(3):266-81
references.pmid: 17634462
references.citation: Int J Endocrinol. 2010;2010:320721
references.pmid: 20016682
references.citation: Clin Pharmacol Ther. 2009 Feb;85(2):198-203
references.pmid: 18754003
references.citation: Transl Res. 2009 Jan;153(1):11-6
references.pmid: 19100953
references.citation: Lancet. 2012 Aug 11;380(9841):545-7
references.pmid: 22607823
references.citation: Ann Pharmacother. 2002 May;36(5):820-3
references.pmid: 11978159
references.citation: Drug Metab Dispos. 1997 Oct;25(10):1191-9
references.pmid: 9321523
references.citation: Methods Find Exp Clin Pharmacol. 2003 Jul-Aug;25(6):457-81
references.pmid: 12949632
references.citation: Drug Metab Dispos. 1990 Jul-Aug;18(4):476-83
references.pmid: 1976071
references.citation: Circulation. 1998 Mar 31;97(12):1129-35
references.pmid: 9537338
references.citation: Dermatoendocrinol. 2010 Apr;2(2):50-4
references.pmid: 21547097
references.citation: Cardiovasc Drugs Ther. 2009 Aug;23(4):261-2
references.pmid: 19618258
references.citation: Clin Pharmacol Ther. 1998 Nov;64(5):477-83
references.pmid: 9834039
references.citation: Eur J Clin Pharmacol. 2004 Feb;59(12):879-82
references.pmid: 14691614
references.citation: Bratisl Lek Listy. 2009;110(10):664-8
references.pmid: 20017462
references.citation: Circulation. 2001 Jan 16;103(2):276-83
references.pmid: 11208689
references.citation: Lancet. 2012 Dec 15;380(9859):2095-128
references.pmid: 23245604
references.citation: Drug Metab Dispos. 2002 May;30(5):505-12
references.pmid: 11950779
references.citation: J Pharmacol Exp Ther. 2011 Jun;337(3):846-59
references.pmid: 21421739
references.citation: Curr Cardiol Rev. 2012 Nov;8(4):253-64
references.pmid: 22920475
references.citation: Cancer Biol Ther. 2005 Aug;4(8):815-8
references.pmid: 16210916
references.citation: J Clin Invest. 1992 Nov;90(5):1871-8
references.pmid: 1430211
references.citation: Ther Drug Monit. 2006 Feb;28(1):39-44
references.pmid: 16418692
references.citation: Drug Metab Dispos. 1996 Oct;24(10):1121-3
references.pmid: 8894514
references.citation: J Sep Sci. 2008 Feb;31(2):301-13
references.pmid: 18196524
references.citation: J Clin Pharmacol. 2005 Apr;45(4):422-33
references.pmid: 15778423
references.citation: South Med J. 2006 Dec;99(12):1385-7
references.pmid: 17233196
references.citation: J Med Case Rep. 2007 Nov 10;1:130
references.pmid: 17996111
references.citation: Clin Pharmacol Ther. 2000 Dec;68(6):592-7
references.pmid: 11180018
references.citation: Eur J Pharm Sci. 2004 Jan;21(1):25-51
references.pmid: 14706810
references.citation: QJM. 2012 May;105(5):487-91
references.pmid: 22323613
references.citation: Clin Pharmacol Ther. 1998 Aug;64(2):177-82
references.pmid: 9728898
references.citation: Pharmacotherapy. 2006 Nov;26(11):1601-7
references.pmid: 17064205
references.citation: Trends Cardiovasc Med. 2005 Aug;15(6):202-6
references.pmid: 16182129
references.citation: QJM. 2009 Dec;102(12):890-1
references.pmid: 19737787
references.citation: Mol Pharmacol. 2012 Jul;82(1):37-46
references.pmid: 22474172
references.citation: Pharmacogenetics. 2004 Aug;14(8):523-5
references.pmid: 15284534
references.citation: Oxid Med Cell Longev. 2012;2012:831748
references.pmid: 23097681
references.citation: Clin Pharmacol Ther. 2006 Dec;80(6):565-81
references.pmid: 17178259
references.citation: Pharmacol Rep. 2007 Sep-Oct;59(5):483-99
references.pmid: 18048949
references.citation: Clin Endocrinol (Oxf). 2009 Jul;71(1):154-5
references.pmid: 19178510
references.citation: Br J Clin Pharmacol. 2005 Nov;60(5):543-51
references.pmid: 16236045
references.citation: Int Cardiovasc Res J. 2013 Jun;7(2):46-50
references.pmid: 24757620
references.citation: Ann Intern Med. 2009 Jun 16;150(12):858-68
references.pmid: 19528564
references.citation: Eur Heart J. 2011 Jul;32(14):1769-818
references.pmid: 21712404
references.citation: Int J Cardiol. 2007 Jul 31;119(3):374-6
references.pmid: 17098308
references.citation: Biochem Pharmacol. 2008 Mar 1;75(5):1240-50
references.pmid: 18177842
references.citation: Hepatology. 1996 Oct;24(4):796-801
references.pmid: 8855178
references.citation: J Biol Chem. 1999 Jul 30;274(31):21926-31
references.pmid: 10419514
references.citation: Am J Cardiol. 1999 Oct 1;84(7):811-5
references.pmid: 10513779
references.citation: Tenn Med. 2001 Sep;94(9):339-41
references.pmid: 11550401
references.citation: South Med J. 2010 Jul;103(7):690-2
references.pmid: 20531048
references.citation: Thromb Res. 1999 Sep 1;95(5):229-34
references.pmid: 10515287
references.citation: Clin Pharmacol Ther. 2005 Sep;78(3):260-77
references.pmid: 16153397
references.citation: J Med Chem. 2012 May 24;55(10):4740-63
references.pmid: 22541068
references.citation: J Pharm Biomed Anal. 1992 Sep;10(9):693-7
references.pmid: 1286134
references.citation: Fundam Clin Pharmacol. 1999;13(2):154-68
references.pmid: 10226759
references.citation: Clin Pharmacol Ther. 2001 Dec;70(6):518-24
references.pmid: 11753267